Endonovo Therapeutics, Inc. (ENDV)

Endonovo Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue Revenue Growth	0.26	0.14	0.07	0.17	0.31	0.08
Revenue Growth	1699.85%	85.15%	-55.91%	-46.55%	272.51%	-
Gross Profit Gross Profit Growth	0.25	0.13	0.06	0.1	0.22	0.07
Operating Income Operating Income Growth	-2.62	-3.26	-2.23	-2.91	-3.81	-4.16
Net Income Net Income Growth	-4.4	-18.47	-3.1	-0.4	-17.31	-6.44
Earnings Per Share EPS Growth	-0.06	-0.13	-0.05	-0.03	-24.83	-17.76
EPS Growth	-	-	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Investments Cash & Investments Growth	0	0	0.09	0.01	0.02	0.38
Total Debt Total Debt Growth	7.06	7.15	7.18	6.63	8.68	7.86
Net Cash (Debt) Net Cash Growth	-7.06	-7.15	-7.1	-6.62	-8.66	-7.48
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.03	-0.05	-0.12	-0.54	-12.41	-20.65

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Operating Cash Flow Operating Cash Flow Growth	-0.63	-0.68	-0.99	-0.74	-2.54	-2.88
Capital Expenditures CapEx Growth	-	-	-	-	-0	-0.01
Free Cash Flow Free Cash Flow Growth	-0.63	-0.68	-0.99	-0.74	-2.54	-2.89
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Gross Margin	96.21%	92.62%	79.50%	60.57%	69.89%	84.47%
Operating Margin	-1023.16%	-2411.69%	-3045.68%	-1756.49%	-1228.08%	-4995.33%
Pretax Margin	-1722.23%	-13649.17%	-4247.17%	-238.60%	-5582.37%	-7729.53%
Profit Margin	-1722.23%	-13649.17%	-4247.17%	-238.60%	-5582.37%	-7729.53%
FCF Margin	-246.32%	-501.52%	-1349.54%	-447.29%	-820.08%	-3468.29%

Valuation

Chart

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jul 30, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
PS Ratio	0.01	25.84	15.37	2.98	6.14	89.88

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error